Daiwa Capital Markets America’s Edwards Lifesciences EW Stock Holding History

Daiwa Capital Markets America’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q4	$217K	Buy	+19,800	New	+$223K	﹤0.01%	627

Other funds holding EW

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Fairpointe Capital Chicago, Illinois $66.3M AUM 101.32% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Jana Partners New York $1.34B AUM 4.95% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Daiwa Capital Markets America's EW Position: Q4 2013 in Review

Daiwa Capital Markets America opened a new position in Edwards Lifesciences (EW) in Q4 2013: 19,800 shares worth $217K. The stake represents ﹤0.01% of the portfolio and ranks #627 among its holdings.

408 funds tracked by Wall St. Rank hold EW as of Q4 2013.

Daiwa Capital Markets America held 19,800 shares of Edwards Lifesciences worth $217K as of Q4 2013.
Edwards Lifesciences was a new Daiwa Capital Markets America position in Q4 2013.
Edwards Lifesciences made up ﹤0.01% of Daiwa Capital Markets America's portfolio in Q4 2013, its #627 holding.
408 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2013.

Based on Daiwa Capital Markets America's 13F filing for Q4 2013, filed 13 Feb 2014.